Insider Transactions Reported by 17 Insiders of Evolus, Inc.

Symbol
EOLS on Nasdaq
Location
Newport Beach, CA

Insiders trading volume in the past year

Evolus, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Alphaeon 1 LLC 10%+ Owner $35,404,916 17 Feb 2023
Medytox Inc. Former 10% Owner $25,359,945 16 Oct 2023
SIMONE BLANK Director $6,075,914 07 Mar 2025
DAVID MOATAZEDI President and Chief Executive Officer, Director $5,421,884 -$2,962,074 -35% 17 Feb 2026
Rui Avelar Chief Medical Officer and Head of R&D $2,525,719 -$419,432 -14% 17 Feb 2026
Sandra Beaver Chief Financial Officer $2,061,242 -$184,313 -8.2% 13 May 2025
Vikram Malik Director $1,611,967 17 Feb 2026
LAUREN P. SILVERNAIL Chief Financial Officer and Executive Vice President, Corporate Development $1,377,288 17 May 2022
Crystal Muilenburg Chief Marketing Officer $1,306,045 08 Mar 2022
Tatjana Mitchell Chief Financial Officer $1,134,981 17 Feb 2026
Tomoko Yamagishi-Dressler Chief Marketing Officer $869,027 -$103,097 -11% 22 Aug 2025
ROBERT HAYMAN Director $856,795 07 Feb 2024
Brady Stewart Director $673,623 +$204,486 +44% 17 Feb 2026
Chairman emeritus Peter C. Farrell Director $517,309 27 Jan 2023
Albert G. White III Director $481,603 +$189,000 +65% 17 Feb 2026
DAVID N. GILL Director $436,172 17 Feb 2026
Karah Parschauer Director $390,264 -$167,465 -30% 17 Feb 2026

Recent Insider Transactions by Companies or Individuals for Evolus, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.